In particular, we show that ACD patients have reduced mucosal levels of CD36, TSP-1 and CD61, also known as ανβ3 integrin or CD51 or vitronectin receptor, which altogether constitute an active complex mediating phagocytosis of apoptotic bodies/debris. The gene discussed is CD36; the disease is granular corneal dystrophy type II.